Re: A prospective study of aspirin use and the risk of pancreatic cancer in women (multiple letters) [4]

Journal of the National Cancer Institute

Volumn 96, Issue 8, 2004, Pages 637-638

  Gensini, Gian Franco ^a,b   Conti, Andrea A ^a,b   Abbate, Rosanna ^a   Schernhammer, Eva ^c   Fuchs, Charles ^c  

^a UNIVERSITY OF FLORENCE   (Italy)

^b IRCCS FONDAZIONE DON CARLO GNOCCHI   (Italy)

^c HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTITHROMBOCYTIC AGENT; NONSTEROID ANTIINFLAMMATORY AGENT; PROSTAGLANDIN SYNTHASE INHIBITOR;

ADULT; BRAIN HEMORRHAGE; CALCULATION; CANCER INCIDENCE; CANCER RISK; CANCER SUSCEPTIBILITY; CARDIOVASCULAR DISEASE; DRUG SAFETY; DRUG UTILIZATION; FEMALE; FOLLOW UP; GASTROINTESTINAL HEMORRHAGE; HUMAN; HYPOTHESIS; LETTER; MEDICAL DECISION MAKING; MEDICAL DOCUMENTATION; OUTCOMES RESEARCH; PANCREAS CANCER; PRIORITY JOURNAL; PROSPECTIVE STUDY; QUESTIONNAIRE; RISK ASSESSMENT; RISK BENEFIT ANALYSIS; CHEMICALLY INDUCED DISORDER; INCIDENCE; NOTE; NURSE; PANCREAS TUMOR; RISK FACTOR; STATISTICS; UNITED STATES; WOMEN'S HEALTH;

ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ASPIRIN; CYCLOOXYGENASE INHIBITORS; FEMALE; HUMANS; INCIDENCE; NURSES; PANCREATIC NEOPLASMS; PLATELET AGGREGATION INHIBITORS; PROSPECTIVE STUDIES; QUESTIONNAIRES; RISK ASSESSMENT; RISK FACTORS; UNITED STATES; WOMEN'S HEALTH;

EID: 2342625425     PISSN: 00278874     EISSN: None     Source Type: Journal    
DOI: 10.1093/jnci/djh109     Document Type: Letter

References (0)